Literature DB >> 16520103

Neonatal thromboembolic emergencies.

Courtney Thornburg1, Steven Pipe.   

Abstract

Thrombosis risk is multifactorial, with interaction of hereditary risk factors and acquired environmental and clinical conditions. Newborns are at particular risk for thrombotic emergencies secondary to the unique properties of their hemostatic system, influences of the maternal-fetal environment, and perinatal complications and interventions. Thrombotic complications range from arterial and venous catheter thrombosis to purpura fulminans. Prompt identification and appropriate management of thrombotic emergencies is critical in avoiding limb-, organ-, and life-threatening complications. Treatment strategies have been extrapolated from adult literature but clinical experience from small-scale neonatal studies has resulted in therapeutic guidelines, which should be individualized for each neonate, taking into consideration age and clinical status.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16520103     DOI: 10.1016/j.siny.2006.01.005

Source DB:  PubMed          Journal:  Semin Fetal Neonatal Med        ISSN: 1744-165X            Impact factor:   3.926


  9 in total

Review 1.  Pediatric antiphospholipid syndrome.

Authors:  Cassyanne L Aguiar; Arzu Soybilgic; Tadej Avcin; Barry L Myones
Journal:  Curr Rheumatol Rep       Date:  2015-04       Impact factor: 4.592

Review 2.  Perinatal stroke: a case-based review.

Authors:  Arvind Sehgal
Journal:  Eur J Pediatr       Date:  2011-06-25       Impact factor: 3.183

Review 3.  Pediatric antiphospholipid syndrome.

Authors:  Jacqueline A Madison; Yu Zuo; Jason S Knight
Journal:  Eur J Rheumatol       Date:  2019-12-03

4.  Pediatric APS: State of the Art.

Authors:  Arzu Soybilgic; Tadej Avcin
Journal:  Curr Rheumatol Rep       Date:  2020-03-03       Impact factor: 4.592

Review 5.  Developmental hemostasis in the neonatal period.

Authors:  Vicente Rey Y Formoso; Ricardo Barreto Mota; Henrique Soares
Journal:  World J Pediatr       Date:  2022-01-04       Impact factor: 2.764

6.  Pulmonary artery thrombus in a premature neonate treated with recombinant tissue plasminogen activator.

Authors:  S D DeMeo; A Sherwood; C D Hornik; R N Goldberg; C M Cotten; M Bidegain
Journal:  J Perinatol       Date:  2014-07       Impact factor: 2.521

7.  Aortic thrombosis successfully treated with local recombinant tissue plasminogen activator in a newborn.

Authors:  Georgia Sarquella-Brugada; Javier Rodríguez-Fanjul; Marta Camprubí Camprubí; Cesar Augusto Arango Posada; Julio Moreno Hernando; Fredy Prada Martínez
Journal:  J Thromb Thrombolysis       Date:  2015-02       Impact factor: 2.300

Review 8.  The Differences Between Childhood and Adult Onset Antiphospholipid Syndrome.

Authors:  Chris Wincup; Yiannis Ioannou
Journal:  Front Pediatr       Date:  2018-11-27       Impact factor: 3.418

9.  Incidence of umbilical vein catheter-associated thrombosis of the portal system: A systematic review and meta-analysis.

Authors:  Iliana Bersani; Fiammetta Piersigilli; Giulia Iacona; Immacolata Savarese; Francesca Campi; Andrea Dotta; Cinzia Auriti; Enrico Di Stasio; Matteo Garcovich
Journal:  World J Hepatol       Date:  2021-11-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.